Cancer in Young Adults 20 to 39 Years of Age: Overview

Seminars in Oncology

Volumn 36, Issue 3, 2009, Pages 194-206

  Bleyer, Archie ^a   Barr, Ronald ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MCMASTER CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; ARTICLE; BRAIN CANCER; BREAST CANCER; BRONCHUS CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CAUSE OF DEATH; COLORECTAL CANCER; EARLY DIAGNOSIS; ETHNIC DIFFERENCE; FOLLOW UP; GENDER; HEAD AND NECK CANCER; HODGKIN DISEASE; HUMAN; KAPOSI SARCOMA; KIDNEY CANCER; LUNG CANCER; MELANOMA; MOUTH CANCER; NONHODGKIN LYMPHOMA; PATIENT CARE; PHARYNX CANCER; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT; RACE DIFFERENCE; RECTUM CANCER; RISK FACTOR; SOFT TISSUE SARCOMA; SPINAL CORD CANCER; SURVIVAL RATE; TESTIS CANCER; THYROID CANCER; UTERINE CERVIX CANCER; VULVA CANCER;

ADULT; CAUSE OF DEATH; FEMALE; HEALTH PLANNING; HUMANS; INCIDENCE; MALE; NEOPLASMS; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 65549147127     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2009.03.003     Document Type: Article

References (36)

1. Bleyer W.A. Adolescents and young adults with cancer: a neglected population. ASCO. Educational Book (2001) 125-132
2. In: Bleyer W.A., O'Leary M., Barr R., and Ries L.A.G. (Eds). Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival, 1975-2000 (June 2006), National Cancer Institute, Bethesda, MD. NIH Pub. No. 06-5767 www.seer.cancer.gov/publications/aya
3. In: Bleyer A., and Barr R.D. (Eds). Cancer in adolescents and young adults (2007), Springer Verlag, New York
4. Closing the gap. Research and care imperatives for adolescents and young adults with cancer. Report of the Adolescent and Young Adult Progress Review Group. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute and LiveStrong Young Adult Alliance; http://planning.cancer.gov/disease/AYAO_PRG_Report_2006_FINAL.pdf(accessed October 12, 2008)
5. http://www.livestrong.org/atf/cf/{D0794917-422C-499C-9C48-9ED3DDC42947}/LAF%20YAA%20Report.pdf accessed October 12, 2008
6. http://planning.cancer.gov/disease/AYA-Snapshot.pdf accessed October 12, 2008
7. http://www.seer.cancer.gov/csr/1975_2005/results_merged/sect_32_aya_cancer.pdf accessed October 12, 2008
8. Bleyer A., Barr R., Hayes-Lattin B., et al. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8 (2008) 288-298
9. Bonnet F., and Chêne G. Evolving epidemiology of malignancies in HIV. Curr Opin Oncol 20 (2008) 534-540
10. Assessing the burden of HPV-associated cancers in the United States. Cancer 113 Suppl 10 (2008) 2837-3057
11. Ryerson A.B., Peters E.S., Coughlin S.S., Chen V.W., Gillison M.L., Reichman M.E., et al. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 113 Suppl 10 (2008) 2901-2909
12. Chaturvedi A., Engels E.A., Anderson W.F., and Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26 (2008) 612-619
13. Garber J.E., and Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol 23 (2005) 276-292
14. Martin S., Ulrich C., Munsell M., et al. Delays in cancer diagnosis in under-insured young adults and older adolescents. Oncologist 12 (2007) 816-824
15. Clemons M., Loijens L., and Goss P. Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treat Rev 26 (2000) 291-302
16. Verrill M.W., Judson I.R., Fisher C., et al. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol 8 (1997) 1099-1105
17. Bleyer A., Budd T., and Montello M. Lack of clinical trial participation and of progress in older adolescents and young adults with cancer. Curr Probl Pediatr Adolesc Health Care 35 (2005) 186-195
18. Bleyer A., Budd T., and Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer 107 Suppl (2006) 1645-1655
19. Bleyer A., Montello M., Budd T., and Saxman S. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer 103 (2005) 1891-1897
20. Stock W., La M., Sanford B., et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols?. A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood 112 (2008) 1646-1654
21. de Bont J.M., van der Holt B., Dekker A.W., et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric versus adult ALL protocols in the Netherlands. B. Leukemia 18 (2004) 2032-2053
22. Boissel N., Auclerc M.F., Lheritier V., et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?. Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 21 (2003) 774-780
23. Testi A. Difference in outcome of adolescents (14-17 years) with acute lymphoblastic leukaemia (ALL) enrolled in the Italian pediatric (AIEOP) an adult (GIMEMA) multicenter treatment protocols [abstract]. Proc Am Society Clin Oncol J Clin Oncol 24 Suppl 18 (2006) 9024
24. Ramanujachar R., Richards S., Hann I., Goldstone A., Mitchell C., Vora A., Rowe J., et al. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer 48 (2007) 254-261
25. Ramanujachar R., Richards S., Hann I., et al. Adolescents with acute lymphoblastic leukaemia: emerging from the shadow of paediatric and adult treatment protocols. Pediatr Blood Cancer 43 (2006) 748-756
26. Paulussen S., Ahrens S., and Juergens H.F. Cure rates in Ewing tumor patients aged over 15 years are better in pediatric oncology units. Results of GPOH CESS/EICESS studies [abstract]. Proc Am Soc Clin Oncol 22 (2003) 816
27. Ferrari A., Dileo P., Casanova M., et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98 (2003) 571-580
28. Ferrari A., Montello M., Budd T., et al. The challenges of clinical trial participation for adolescents and young adults with cancer. Pediat Blood Cancer 50 (2008) 1101-1104
29. Ganz P.A., Greendale G.A., Petersen L., et al. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21 (2003) 4184-4193
30. Phillips K.-A., Osborne R.H., Giles G.G., et al. Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study. J Clin Oncol 26 (2008) 4666-4671
31. Yoon J., Malin J.L., Tao M.L., et al. Symptoms after breast cancer treatment: are they influenced by patient characteristics?. Breast Cancer Res Treat 108 (2008) 153-165
32. Lee S.J., Schover L.R., Partridge A.H., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24 (2006) 2917-2931
33. Roberts J.E., and Oktay K. Fertility preservation: a comprehensive approach to the young woman with cancer. Natl Cancer Inst Monogr 34 (2005) 57-59
34. Davis M. Fertility considerations for female adolescent and young adult patients following cancer therapy: a guide for counseling patients and their families. Clin J Oncol Nurs 10 (2006) 213-219
35. www.fertilehope.org/learn-more/cancer-and-fertility-info/fertility-risks.cfm Accessed March 29, 2009
36. Bleyer A. Young adult oncology: the patients and their survival challenges. CA Cancer J Clin 57 (2007) 242-255